scholarly journals Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients

2020 ◽  
Vol 17 (14) ◽  
pp. 2113-2124
Author(s):  
Lijun Zhao ◽  
Yutong Zou ◽  
Junlin Zhang ◽  
Rui Zhang ◽  
Honghong Ren ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Serum Transferrin ◽  
Stage Renal Disease ◽  
End Stage

Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus

Cytokine ◽  
2017 ◽  
Vol 92 ◽  
pp. 75-79 ◽  
Author(s):  
Giuseppe Derosa ◽  
Carmelo Libetta ◽  
Pasquale Esposito ◽  
Ilaria Borettaz ◽  
Carmine Tinelli ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Inflammatory Markers ◽  
Stage Renal Disease ◽  
End Stage

Contribution of HLA class II genes to end stage renal disease in Mexican patients with type 2 diabetes mellitus

2000 ◽  
Vol 61 (10) ◽  
pp. 1031-1038 ◽  
Author(s):  
Elva Pérez-Luque ◽  
Juan Manuel Malacara ◽  
Angélica Olivo-Dı́az ◽  
Carmen Aláez ◽  
Héctor Debaz ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Class Ii ◽  
Hla Class Ii ◽  
Stage Renal Disease ◽  
End Stage

2234-PUB: A Risk Prediction Model for End-Stage Renal Disease in Patients with Type 2 Diabetes Mellitus

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2234-PUB
Author(s):  
DANIELA GEBA ◽  
JEANINE M. CORDOVA ◽  
SHARASH SHETTY ◽  
BRENT WILLIAMS
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Renal Disease ◽  
Prediction Model ◽  
Risk Prediction ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Projected burden of type 2 diabetes mellitus-related complications in Singapore until 2050: a Bayesian evidence synthesis

2020 ◽  
Vol 8 (1) ◽  
pp. e000928
Author(s):  
Ken Wei Tan ◽  
Borame Sue Lee Dickens ◽  
Alex R Cook
Keyword(s):  
Diabetes Mellitus ◽  
Myocardial Infarction ◽  
Type 2 Diabetes ◽  
Acute Myocardial Infarction ◽  
Type 2 Diabetes Mellitus ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage

ObjectiveWe examined the effects of age, gender, and ethnicity on the risk of acute myocardial infarction, stroke, and end-stage renal disease according to type 2 diabetes mellitus status among adults aged 40–79 in Singapore.MethodsA Bayesian inference framework was used to derive age-specific, gender-specific and ethnicity-specific prevalence of type 2 diabetes mellitus from the 2010 Singapore National Health Survey, and age-standardized gender and ethnicity-specific incidence rates of acute myocardial infarction, stroke and end-stage renal disease from the National Registry of Diseases Office. Population forecasts were used in tandem with incidence rates to project the future chronic disease burden until 2050.ResultsThe highest relative risk of acute myocardial infarction was observed in the youngest age group (aged 40–44), with higher relative risk for women (men: 4.3 (2.7–6.4); women: 16.9 (9.3–28.3)). A similar trend was observed for stroke (men: 6.5 (4.2–9.7); women: 10.7 (6.0–17.4)). For end-stage renal disease, the highest relative risk was for men aged 45–50 (11.8 (8.0–16.9)) and women aged 55–60 (16.4 (10.7–24.0)). The annual incidence of acute myocardial infarction is projected to rise from 9300 (in 2019) to 16 400 (in 2050), the number of strokes from 7300 to 12 800, and the number of end-stage renal disease cases from 1700 to 2700.ConclusionsType 2 diabetes mellitus was associated with an increased risk of complications and is modulated by age and gender. Prevention and early detection of type 2 diabetes mellitus can reduce the increasing burden of secondary complications.

Sign in / Sign up

Export Citation Format

Share Document